Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
- 17 August 2007
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 35 (2), 174-179
- https://doi.org/10.1111/j.1600-0560.2007.00783.x
Abstract
Evaluation of androgen receptor (AR) and cytokeratin 20 (CK20) expression can aid in distinguishing between conventional basal cell carcinoma (characteristically AR+, CK20-) and trichoepithelioma (frequently AR-, CK20+). Within these two groups of tumors, morpheaform/infiltrative basal cell carcinoma (mBCC) and desmoplastic trichoepithelioma (DTE) are particularly challenging to differentiate both clinically and histologically. We investigated whether AR and CK20 immunostains may distinguish between mBCC and DTE. Immunohistochemistry for AR and CK20 was performed on 15 DTEs and 31 mBCCs. Any immunoreactivity within the tumor for AR or CK20 was considered positive. AR expression was seen in 13% (2/15) of DTE and 65% (20/31) of mBCC cases (chi-square p = 0.0011). CK20-positive Mërkel cells were identified in 100% (15/15) of DTE and 3% (1/31) of mBCC (chi-square p < 0.0001). The expected pattern of AR-, CK20+ immunophenotype was present in 87% (13/15) of DTE cases. In mBCC, 61% (19/31) was AR+, CK20-. No DTE was AR+, CK20- and no mBCC was AR-, CK20+. Immunohistochemical stains for AR and CK20 are useful to differentiate DTE from mBCC. The AR-, CK20+ immunophenotype is sensitive (87%) and specific for DTE (100%). The AR+, CK20- immunophenotype is specific (100%) and moderately sensitive (61%) for mBCC.Keywords
This publication has 15 references indexed in Scilit:
- Expression of Androgen Receptor by Fibroepithelioma of Pinkus: Evidence Supporting Classification as a Basal Cell Carcinoma Variant?The American Journal of Dermatopathology, 2007
- Familial desmoplastic trichoepitheliomaInternational Journal of Dermatology, 2006
- Elevated Expression of Angiogenin in Prostate Cancer and Its PrecursorsClinical Cancer Research, 2005
- Chemistry and Structural Biology of Androgen ReceptorChemical Reviews, 2005
- Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinomaJournal of Cutaneous Pathology, 2005
- Androgen Receptor Expression Helps to Differentiate Basal Cell Carcinoma from Benign Trichoblastic TumorsThe American Journal of Dermatopathology, 2005
- Risk of prostate carcinoma death in patients with lymph node metastasisCancer, 2001
- Merkel Cells and Sclerosing Epithelial NeoplasmsThe American Journal of Dermatopathology, 2000
- Stromelysin-3The American Journal of Dermatopathology, 1998
- Criteria for histologic differentiation of desmoplastic trichoepithelioma (sclerosing epithelial hamartoma) from morphea-like basal-cell carcinomaThe American Journal of Dermatopathology, 1985